ENLV — Enlivex Ltd.
—
Nasdaq ·
Financials ·
Consumer Finance ·
CIK 1596812 ·
Israel
Last close
$1.15
Market Cap
$20.11M
52W High
$27.15
52W Low
$0.17
ADV30
1,574,688
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -4,232,000 | 1,891,614,000 | 4,899,966,000 | 5,518,000 | 1,001,727,000 |
| Dec 2025 | 0 | — | -5,861,000 | 1,243,053,000 | 2,326,998,000 | 1,894,000 | 392,050,000 |
| Sep 2025 | 0 | — | -2,557,000 | -2,205,000 | 20,938,000 | 4,083,000 | 3,457,000 |
| Jun 2025 | 0 | — | -3,078,000 | -1,868,000 | 22,598,000 | 1,892,000 | 3,544,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-10,416,000
Investing CF
$-1,323,000
Financing CF
$10,381,000
CapEx
$-68,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$93.00
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$3,057,468,000
Inventory
—
Receivables
$310,000
ST Investments
$0
EBIT TTM
$-15,728,000
Pretax Income TTM
$4,079,937,000
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -15,000,000 | 1,235,528,000 | 2,326,998,000 | 392,050,000 | 1,934,948,000 | -10,416,000 |
| Dec 2024 | 0 | -14,931,000 | -15,014,000 | 27,687,000 | 4,098,000 | 23,589,000 | -13,008,000 |
| Dec 2023 | 0 | -25,151,000 | -29,068,000 | 36,831,000 | 6,747,000 | 30,084,000 | -23,523,000 |
| Dec 2022 | 0 | -25,797,000 | -31,060,000 | 67,642,000 | 10,801,000 | 56,841,000 | -23,953,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.78
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CRSF | Crisp Momentum Inc. | $19.70M | $0.01 | — |
| AURE | Aurelion Inc. | $19.61M | $0.88 | — |
| JFU | 9F Inc. | $18.74M | $2.15 | — |
| NCPL | Netcapital Inc. | $18.60M | $2.37 | — |
| ARBK | Argo Blockchain Plc | $18.15M | $1.24 | — |
News headlines (Yahoo Finance, 1h cache)
Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response
2026-11-02 13:00 · Yahoo
Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
2026-10-28 12:00 · Yahoo
Enlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
2026-09-01 13:55 · Yahoo
Enlivex Ltd. (ENLV) Upgraded to Buy: Here's Why
2026-07-13 16:00 · Yahoo
Exclusive: FDA grants RMAT designation to Enlivex’s Allocetra for knee OA
2026-07-13 11:30 · Yahoo
Enlivex advances Allocetra while expanding into prediction markets
2026-05-11 14:41 · Yahoo
H.C. Wainwright Highlight Improved Balance Sheet Supporting Enlivex Ltd. (ENLV) Outlook
2026-04-21 02:46 · Yahoo
Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress
2026-04-23 12:30 · Yahoo
Enlivex Ltd. (ENLV) Loses 31.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
2026-07-13 13:35 · Yahoo
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares
2026-04-08 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.